Nan Shan Life Insurance’s Lam Research LRCX Stock Holding History

Nan Shan Life Insurance’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.18M	Sell	7,338 -39,237	-84%	-$11.9M	0.1%	77
2026 Q1	$9.95M	Buy	+46,575	New	+$10.4M	0.36%	59
2020 Q3	–	Sell	-130,000	Closed	-$4.21M	–	113
2020 Q2	$4.21M	Sell	130,000 -497,000	-79%	-$13.6M	0.13%	83
2020 Q1	$15M	Buy	+627,000	New	+$18.1M	0.55%	49
2017 Q4	–	Sell	-9,462,930	Closed	-$175M	–	87
2017 Q3	$175M	Buy	9,462,930 +8,966,930	+1,808%	+$145M	3.62%	9
2017 Q2	$7.01M	Sell	496,000 -2,112,770	-81%	-$31M	0.18%	48
2017 Q1	$33.5M	Buy	+2,608,770	New	+$30.7M	0.83%	35

Other funds holding LRCX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nan Shan Life Insurance's LRCX Position: Q2 2026 in Review

Nan Shan Life Insurance reduced its Lam Research (LRCX) stake by 84% in Q2 2026, selling an estimated $11.9M and leaving 7,338 shares worth $3.18M. The position accounts for 0.1% of the portfolio, ranked #77.

Nan Shan Life Insurance first reported a position in LRCX in Q1 2017 and has held it in 7 quarters since. The position peaked at $175M in Q3 2017. 3,130 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

Nan Shan Life Insurance held 7,338 shares of Lam Research worth $3.18M as of Q2 2026.
Nan Shan Life Insurance sold 39,237 Lam Research shares in Q2 2026, an estimated $11.9M.
Lam Research made up 0.1% of Nan Shan Life Insurance's portfolio in Q2 2026, its #77 holding.
Nan Shan Life Insurance first reported a position in Lam Research in Q1 2017 and has held it in 7 quarters since.
Nan Shan Life Insurance's Lam Research position peaked at $175M in Q3 2017.
3,130 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Nan Shan Life Insurance's 13F filing for Q2 2026, filed 14 Aug 2026.